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Abstract. 
 
Cells of the mononuclear phagocyte lineage 
have the capability to adhere to and fuse with each 
other and to differentiate into osteoclasts and giant 
cells. To investigate the macrophage adhesion/fusion 
mechanism, we focused our attention on CD44, a sur-
face glycoprotein known to play a role in hematopoietic 
cellÐcell adhesion. We report that CD44 expression by 
macrophages is highly and transiently induced by fuso-
genic conditions both in vitro and in vivo. We show that 
CD44 ligands, hyaluronic acid, chondroitin sulfates, 
and osteopontin prevent macrophage multinucleation. 
In addition, we report that the recombinant extracellu-
lar domain of CD44 binds fusing macrophages and pre-
vents multinucleation in vitro. These data suggest that 
CD44 may control the mononucleated status of mac-
rophages in tissues by virtue of mediating cellÐcell in-
teraction.
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M
 
ononuclear
 
 phagocytes are cells which have
the potential, in specific instances, to fuse and
differentiate into either osteoclasts or multinu-
cleated giant cells, in bone or in chronic inflammatory re-
actions, respectively. Multinucleation appears to endow
mononuclear phagocytes with an added value, i.e., a pow-
erful resorptive capability of extracellular components,
i.e., bone or infectious agents (Vignery et al., 1989). In-
deed, osteoclasts are responsible for the loss of bone that
leads to osteoporosis.
Although osteoclasts and giant cells have long been rec-
ognized, the molecular mechanism by which their mono-
nucleated precursors adhere and fuse with each other, a
key step in their differentiation, remains poorly under-
stood. Indeed, cellÐcell fusion itself, whether it concerns
that of spermÐoocyte or myoblastÐmyoblast, leading to
fertilization and muscle development, respectively, has not
been thoroughly investigated. It is thought that cellÐcell
adhesion leading to fusion involves a set of proteins simi-
lar to those used by viruses to fuse with host cells and in-
ject their DNA or RNA (Hernandez et al., 1997). It has
been hypothesized that viruses have stolen the fusion
protein machinery from their target cells. It is now well
accepted that virusÐcell fusion requires both an attach-
ment mechanism and a fusion peptide. One such example
is HIV gp120 from the human immunodeficiency virus
(HIV)
 
1
 
 which binds CD4 on T lymphocytes and macro-
phages (Dalgleish et al., 1984; Klatzmann et al., 1984),
whereas the fusion molecule gp40, which arises from the
same precursor molecule (gp160), is thought to trigger the
actual fusion event. Although putative fusion molecules
mediating spermÐoocyte and myoblast fusion have been
reported (Blobel et al., 1992; Wakelam 1989), the actual
protein machinery governing the attachment and fusion of
these cells remains unknown.
Increasing evidence suggests that the molecular machin-
ery mediating virusÐcell and cellÐcell adhesion/fusion is
more complicated than anticipated and involves numerous
players. Although it had been thought that HIV needed
only the T lymphocyte receptor CD4 to bind and infect
cells, several chemokines have now been demonstrated to
slow the growth of HIV in cultures. It has been deter-
mined that the chemokine family of G proteinÐcoupled re-
ceptors, most notably CC-CKR4 and CC-CKR5, are in-
volved in HIV infection (Alkhatib et al., 1996; Deng et al.,
1996; Dragic et al., 1996; Feng et al., 1996). There are now
at least 10 chemokine receptors identified as HIV core-
ceptors (Dimitrov, 1997). Furthermore, the interaction
between the adhesion molecules leukocyte function-asso-
ciated antigen-1 (LFA-1) and intercellular adhesion mole-
cule-1 (ICAM-1) has been described with respect to
both  virusÐcell and cellÐcell adhesion/fusion events. HIV-
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Abbreviations used in this paper
 
:
 
 
 
CSA, chondroitin sulfate A; Cy3, in-
docarbocyanine; HA, hyaluronic acid; HIV, human immunodeficiency vi-
rus; LFA-1, leukocyte function-associated antigen-1; nt, nucleotide(s);
OP, osteopontin; RT, reverse transcription.
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induced syncytium formation is blocked by a monoclonal
antibody directed against the 
 
b
 
 subunit of LFA-1 (Hild-
reth and Orentas, 1989), whereas cytokine induced multi-
nucleate giant cell formation from peripheral blood mono-
cyte (Mst et al., 1990; Kazazi et al., 1994) as well as
osteoclast development in vitro (Kurachi et al., 1993) are
both inhibited by antibodies directed against LFA-1 and
ICAM-1. The expression level of these molecules, how-
ever, does not correlate with multinucleation (Kurachi et
al., 1993). Members of the cadherin family of homophilic
cell adhesion molecules have also been suggested to play a
role in cellÐcell multinucleation. Although N-cadherin ap-
pears necessary for myoblast fusion (Mege et al., 1992), in-
hibition of E-cadherin function prevents the fusion of os-
teoclast precursors in vitro (Mbalaviele et al., 1995). A set
of proteins thought to enhance or induce cell fusion, ini-
tially termed FRP-1 and FRP-2 and now known to be
CD98 and integrin 
 
a
 
3, respectively (Ohgimoto et al., 1995;
Higuchi et al., 1998), have been recently identified in a
number of cell lines infected with several different viruses
as well as on the surface of monocytes and macrophages.
Monoclonal antibodies directed against these proteins
stimulate polykaryocyte formation in CD4
 
1
 
 U937 cells
transfected with the HIV gp160 gene (Ohta et al., 1994)
and in HeLa and FL cells infected with Newcastle disease
virus (Ito et al., 1992). In addition, anti-FRP antibodies in-
hibit giant cell formation in cultures of peripheral blood
monocytes (Tabata et al., 1994). Most recently, overex-
pression of the purigenic P2Z/P2X
 
7
 
 has been reported to
trigger cellÐcell fusion but also leads to cell death (Falzoni
et al., 1995; Chiozzi et al., 1997). Although none of these
proteins appear as actual fusion proteins and may not
therefore mediate the actual fusion event, together they
suggest that the fusion mechanism of viruses and mamma-
lian cells may involve both regulatory proteins and adhe-
sion molecules.
CD44 is an integral membrane glycoprotein which plays
an important role in both cellÐcell and cellÐsubstrate adhe-
sion (Belitsos et al., 1990; Stamenkovic et al., 1991; Sy et al.,
1991). CD44 exists as different isoforms in a wide variety
of cells and tissues due to posttranslational modifications
and alternative splicing (Tolg et al., 1993; for review see
Naor et al., 1997). Our interest in CD44 as a protein that
might be important for macrophage multinucleation was
prompted by the following criteria: first, CD44 is involved
in cell migration, lymphopoiesis and lymphocyte homing,
in which it mediates cellÐcell and cellÐsubstrate interac-
tions. A substantial body of data has been published sug-
gesting that certain molecules involved in cellÐcell adhe-
sion, such as CD4 and LFA-1, play an important role in
the infectivity and cytopathicity of viruses. (Pantaleo et al.,
1991). Second, CD44 recognizes and binds to extracellular
matrix elements such as hyaluronate (Lesley et al., 1990;
Miyake et al., 1990), collagen type I, fibronectin (Jalkanen
and Jalkanen, 1992) and osteopontin (Weber et al., 1996).
The interaction of CD44 with extracellular components, in
addition to cell surface molecules, could provide an addi-
tional regulatory mechanism to control multinucleation in
macrophages. Third, the 100-kD form of CD44, the most
common so-called standard form expressed by hematopoi-
etic cells, has been demonstrated to be involved not only
in the attachment of poliovirus to HeLa cells (Shepley and
Racaniello, 1994) but also in the infection of mononuclear
phagocytes by HIV (Rivandeneira et al., 1995). CD44 does
not, however, act as a viral receptor in either of these two
instances. We therefore set out to investigate whether
CD44 played a role in macrophage multinucleation. We
report here that CD44 expression by macrophages is
highly and transiently induced by fusogenic conditions,
and that CD44 ligands prevent multinucleation. We also
show that the recombinant soluble extracellular domain of
CD44 binds macrophages and prevents multinucleation in
vitro. This suggests that CD44 and its putative cellÐsurface
ligand may participate in the adhesion/fusion event of
macrophages.
 
Materials and Methods
 
Cells
 
Rat alveolar macrophages were obtained from 12-wk-old Fisher rats
(Charles River, Kingston, NY) by tracheobronchial lavage and cultured in
fusogenic conditions as previously described (Vignery et al., 1990). Osteo-
clast-like cells were elicited in vivo by implanting syngeneic bone particles
intramuscularly for 10 d in 12-wk-old Sprague Dawley rats (Charles
River) as previously described (Vignery et al., 1989; 1990). The National
Research CouncilÕs guide for the care and use of laboratory animals were
followed. COS-7 cells were a gift of M. Solimena (Yale School of Medi-
cine, New Haven, CT).
 
Chemicals
 
Hyaluronic acid from human umbilical cord was purchased from Calbio-
chem-Novabiochem (La Jolla, CA) and Pharmacia Biotech (Uppsala,
Sweden). Chondroitin sulfate A from bovine trachea and chondroitin sul-
fate B were purchased from Calbiochem-Novabiochem. Osteopontin was
a kind gift of W.T. Butler (Texas Medical Center Dental Branch, Hous-
ton, TX). Unless otherwise stated, all chemicals were purchased from
Sigma Chemical Co. (St. Louis, MO).
 
Antibodies
 
Mouse antiÐrat macrophage CD44 (MRC OX8), CD4 (W3/25), and
MHCII (RT1B) which are of the IgG1 isotype, were obtained from Sero-
tec (Raleigh, NC). Fluorescein isothiocyanate (FITC)-conjugated F(ab)
 
9
 
2
goat antiÐmouse IgG (H 
 
1 
 
L chains) was obtained from Boehringer Mann-
heim Biochemicals (Indianapolis, IN). Indocarbocyanine (Cy3)-conju-
gated F(ab)
 
9
 
2 goat antiÐmouse IgG (H 
 
1 
 
L chains) and goat antiÐmouse
IgG horseradish peroxidase conjugate were obtained from Jackson Immu-
noResearch Laboratories (West Grove, PA). Goat anti-GST and rabbit
antiÐgoat IgG conjugated to horseradish peroxidase were obtained from
Pharmacia Biotech. Mouse anti-myc was purchased from Invitrogen
(Carlsbad, CA), and sheep antiÐmouse horseradish peroxidase conjugate
was purchased from Amersham (Arlington Heights, IL).
 
Immunolocalization
 
Tissues were prepared from both control and experimental rats implanted
with bone particles (Vignery et al., 1989). The implants and the rat tissues
were quick frozen and cut to 6-
 
m
 
m-thick frozen sections using a Reichert-
Jung cryostat (2800 Frigocut; Leica, Deerfield, IL). The sections were first
incubated overnight in PBS-milk (PBS supplemented with 5% nonfat dry
milk [Carnation, Los Angeles, CA]), then for 2 h in PBS-milk containing
anti-CD44, anti-CD4, anti-MHCII, or mouse IgG1. Sections were then in-
cubated for 1 h in PBS-milk containing a 1:400 dilution of goat antiÐmouse
Cy3-F(ab)
 
9
 
2. After three washes of 10 min each with PBS, the sections
were imaged at 550 nm using the Cy3 excitation filter block on an Olym-
pus microscope (Melville, NY) equipped with UV light. Cells were cul-
tured on glass coverslips for the indicated time in MEM containing 5%
human serum, fixed in formaldehyde for 1 h at 4
 
8
 
C, and then washed for
60 min in PBS-FCS (PBS 
 
1
 
 10% FCS). The cells were incubated over-
night in PBS-FCS supplemented or not with anti-CD44, anti-CD4, anti-
MHCII, or mouse IgG1. After four washes of 15 min each in PBS-FCS
(PBS with 10% FCS), the cells were incubated for an additional hour with 
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FITC-conjugated F(ab)
 
9
 
2 goat antiÐmouse IgG (1:100 and 1:400 dilutions,
respectively) in the same buffer. The cells were imaged at 488 nm using
the FITC excitation filter block on an Olympus microscope equipped with
UV light.
 
RNA Isolation and Northern Blot Analysis
 
Total RNA was isolated from alveolar and peritoneal macrophages cul-
tured or not in fusogenic milieu for 72 h using a modification (Maniatis
et al., 1989) of the methods described by Glisin et al. (1974) and Ullrich et
al. (1977) or the RNeasy kit (QIAGEN, Santa Clarita, CA). In each case,
guanidinium thiocyanate homogenization buffer was added to the freshly
isolated, and the cultured cells after rapid removal of culture medium. The
cell lysates were sheared using a syringe with a 23-gauge needle (Becton
Dickinson, Franklin Lakes, NJ). For separation by cesium chloride, 2.5
ml-aliquots of the lysate were layered onto a 2-ml cushion of 5.7 M cesium
chloride (American Bioanalytical, Natick, MA) in RNase-free 5.1-ml
polyallomer centrifuge tubes which were centrifuged at 150,000 
 
g
 
 for 20 h
using a Ti 55 SW rotor. The supernatants were aspirated and the pellets
dissolved in Tris-EDTA, pH 7.4, containing 0.1% SDS by freezing and
thawing the samples twice and then warming to 45
 
8
 
C. RNA was precipi-
tated by the addition of 0.3 M sodium acetate and 3 vol of ethanol. The
pellets were resuspended in diethylpyro carbonate (DEPC)-treated water
and the concentration determined using optical density measurements
taken in a Perkin Elmer UV/VIS spectrophotometer (Foster City, CA).
For Northern blot analysis, 8 
 
m
 
g of each RNA sample was electro-
phoretically separated in formaldehyde-agarose gels, blotted onto a nylon
membrane (GeneScreen Plus; New England Nuclear, Boston, MA) and
hybridized with a 
 
32
 
P-labeled PCR-generated DNA probe corresponding
to the full-length CD44 cDNA. The signals on the autoradiogram were
quantitated using a Linotype-Hell scanner (Eschborn, Germany) with a mul-
tianalyst software for Macintosh (Bio-Rad Laboratories, Hercules, CA).
 
cDNA Synthesis and PCR
 
First-strand cDNA was synthesized as follows: 1 
 
m
 
g of total RNA was re-
verse transcribed using 200 U of MMLV reverse transcriptase (Boeh-
ringer Mannheim Biochemicals) in a 20-
 
m
 
l reaction primed with oligo
dT15 primer (Promega, Springfield, NJ). The protocol followed was that
published in the instruction manual from Clontech (Palo Alto, CA). The
cDNA was aliquoted and stored at 
 
2
 
70
 
8
 
C. For PCR reaction, 1 
 
m
 
l of
cDNA was used as template in a 25-
 
m
 
l reaction mix containing 2.5 U of
AmpliTaq DNA polymerase (Perkin Elmer), 1.25 mM MgCl
 
2
 
,
 
 
 
and 0.1 mM
DNTP mix (New England Biolabs, Beverly, MA). The buffer condition
used for the PCR was a 1
 
3
 
 dilution of the 10
 
3 
 
mix provided with the
polymerase. The sequences of the primer pairs (used at a concentration of
0.1 
 
m
 
g per reaction) were as follows: full-length CD44: primer forward
(nucleotide [nt] 87Ð122): GATCCTTTGGTTGCTAGCTGCACAT-
CATGGACAAGG; reverse primer (nt 1187Ð1225): AAGTTAGTG-
GCACTCGAGCTACACCCCAATCTTCATATC; CD44 extracellular
domain: primer forward (nt 86Ð122): AGATCCTTTGGCTCGAGCCT-
GCACATCATCGACAAGG; reverse primer (nt 878Ð913): AGGTCTC-
CTCGCGAATTCAGAAGTTGTGGTCACTCC; CD44 intracellular
domain: primer forward (nt 994Ð1012): TAGGAGAAGGTGTGG-
GCAG; reverse primer (nt 1195Ð1212): AGGCACTACACCCCAATC.
Cycle parameters were: 3 min at 95
 
8
 
C, 1 min at 50
 
8
 
C, and 3 min at 72
 
8
 
C for
30 cycles. The PCR fragment was gel purified using Geneclean (Bio 101;
Branford, CT) and cloned into PCR II TA cloning vector (Invitrogen, San
Diego, CA). The cloned DNA insert was sequenced (W.M. Keck Biotech-
nology Resource Laboratory, Yale University) using AmpliTaq DNA
polymerase and fluorescent dideoxy terminators (Perkin Elmer) in a cycle
sequencing method. The resulting DNA fragments were gel purified and
analyzed using an automated Applied Biosystems 373A Stretch or 377
DNA sequencer (Foster City, CA).
 
CD44, CD4, and MHCII ELISA
 
The levels of CD44, CD4, and MHCII cell surface expression were quanti-
tated by ELISA as follows: 5 
 
3 
 
10
 
4
 
 alveolar macrophages per well plated
at 5 
 
3 
 
10
 
6
 
 cells/ml in 96-well dishes were cultured for the indicated times.
The minimum culture time after plating in each experiment was 1 h in or-
der to secure the adherence of the cells to the wells. They were fixed at
room temperature in 4% paraformaldehyde for 10 min, then incubated in
100 
 
m
 
l of PBS supplemented with 5% dry milk for 2 h. The cells were sub-
sequently reacted overnight with IgG1, anti-rat CD44 (10Ð50 
 
m
 
g/ml), anti-
rat CD4 (100 
 
m
 
g/ml), or anti-rat MHCII (10Ð50 
 
m
 
g/ml). After three
washes of 10 min each with PBS, the cells were incubated at room temper-
ature for 2 h with goat antiÐmouse IgG horseradish peroxidase conjugate
(1:5,000 dilution). The cells were washed three times for 10 min with PBS.
Surface CD44 expression was quantitated by incubating the cells for 5 min
in 100 
 
m
 
l of 3,3
 
9
 
5,5
 
9
 
-tetramethylbenzidine (HRP substrate; Moss, Pasa-
dena, MD). Optical density measurements were made using a kinetic
reader (Molecular Devices, Sunnyvale, CA).
 
Treatment of Cells with Glycosaminoglycans
and Osteopontin
 
10-
 
m
 
l aliquots of 5 
 
3 
 
10
 
6
 
 rat alveolar macrophages/ml were plated in flat
bottom 96-well tissue culture dishes that had been treated overnight at
37
 
8
 
C with hyaluronic acid (1 mg/ml) or chondroitin sulfate A or B (1 mg/ml).
Glycosaminoglycans and osteopontin were stored in lipopolysaccharide
(LPS)-free H
 
2
 
O as 10-mg/ml and 10-
 
m
 
M stock solutions, respectively,
which were diluted in MEM and filter-sterilized just before use. The cells
were cultured for 4 d in 100 
 
m
 
l of MEM supplemented with different con-
centrations of hyaluronic acid, chondroitin sulfate A or B, and osteopon-
tin. In experiments in which HA was obtained from Pharmacia, HA was
added to the cells every day in fresh medium. Competition binding studies
were performed by supplementing mAb anti-CD44 with
 
 
 
1 mg/ml
 
 
 
hyal-
uronic acid, chondroitin sulphate A, chondroitin sulphate B, or 1 
 
m
 
M os-
teopontin. CD44 expression was determined by ELISA, as described
above.
 
Production of CD44e: The Recombinant Soluble 
Extracellular Domain of CD44
 
The recombinant extracellular domain of CD44 (CD44e) was expressed
using two different systems. CD44e was expressed as a fusion protein
using the GST fusion protein system (Pharmacia Biotech). PCR ampli-
fication of this region was performed with a sense (5
 
9
 
TTACA-
GTTGAGCGAATTCCAGCAGCAGATCGATTTGAA; nt 158Ð195),
and an antisense primer (5
 
9
 
AGGTCTCCTCGCCTCGAGAGAAG-
TTGTGGTCACTCC; nt 878Ð913), using rat macrophage cDNA as tem-
plate (made from total RNA) and PWO as polymerase (Boehringer Mann-
heim, Mannheim, Germany). The primers were designed to allow
digestion of the resulting PCR fragment with EcoR1 and Xho1 by means
of which it was ligated in frame into an EcoR1-Xho1 cut pGEX-4T-1 vec-
tor. The resulting construct encoded a fusion protein of 
 
z
 
50 kD and was
used to transform the protease-deficient 
 
Escherichia coli
 
 strain BL-21.
Soluble GSTÐCD44e was isolated from 1 liter of bacterial culture using
the bulk GST purification module as described by the manufacturer. The
eluted protein was extensively dialyzed against PBS and stored at 
 
2
 
70
 
8
 
C
until ready for use. As a control, a pGEX-calreticulin construct was ob-
tained courtesy of A. Helenius (Yale University) and GST-calreticulin
was isolated and stored as described above.
CD44e was expressed in mammalian cells with a Myc-His fusion tag us-
ing the mammalian expression vector pcDNA 3.1/Myc-His A, B, C (Invi-
trogen, Carlsbad, CA). PCR amplification of the extracellular region was
performed with a sense primer (5
 
9
 
AGATCCTTTGGTGAATTCC-
TGCACATCATGGACAAGG; nt 86Ð122) an antisense primer (5
 
9
 
AG-
GTCTCCTCGCGAATTCAGAAGTTGTGGTCACTCC; nt 878Ð913),
and rat macrophage cDNA as a template and PWO polymerase. The PCR
product was digested with EcoRI and ligated into the EcoRI site of
pcDNA 3.1/Myc-His B. This construct was used to transfect COS-7 cells
using lipofectamine (GIBCO BRL, Gaithersburg, MD) according to the
manufacturerÕs instructions. Transfected cells were cultured for 72 h in
Opti-MEM I reduced serum medium (GIBCO BRL). The recombinant
protein was purified from culture supernatant using InvitrogenÕs Xpress
protein purification system. Recombinant GSTÐCD44e was quantified by
running 5 
 
m
 
l on a 10% SDS-polyacrylamide gel and staining with Coo-
massie brilliant blue. The intensity of the stained band was tested against
that of a serial dilution of bovine serum albumin (BSA) run on the same
gel. The concentration of Myc-HisÐCD44e was then determined by immo-
bilizing serial dilutions of both GSTÐCD44e and Myc-HisÐCD44e on ni-
trocellulose using a Bio-Dot microfiltration apparatus (Bio-Rad Labora-
tories). The immobilized proteins were reacted with antiÐCD44 mAb
followed by horseradish peroxidase (HRP)-linked sheep antiÐmouse IgG
(ECL kit; Amersham). The enzyme reaction was performed according to
the manufacturerÕs instructions and the blots exposed for 30 s on X-ray
films. Recombinant Myc-His-CD44e concentration was determined by
comparative scanning densitometry of the dots against the concentration
of GSTÐCD44e. 
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Deglycosylation of Recombinant Myc-His-CD44e
 
Approximately 250 
 
m
 
g of recombinant Myc-His-CD44e was deglycosy-
lated in its native form by incubation with 10 U of N-glycosidase F for 48 h
at 37
 
8
 
C in 0.1 M sodium phosphate, pH 7.4. Deglycosylation was analyzed
by comparative Western blot analysis of both native and N-glycosidase F
(Boehringer Mannheim, Indianapolis, IN)-treated Myc-His-CD44e using
anti-myc antibody (Invitrogen).
 
Fusion Assay Using Recombinant Proteins
 
Freshly isolated rat alveolar macrophages were plated at 5 
 
3 
 
10
 
6
 
 cells/ml
and cultured in fusogenic milieu supplemented with either GSTÐCD44e,
GST-Cal, or GST at the indicated concentrations. The cells were exam-
ined daily until day 4 to determine the effects of fusion proteins on mac-
rophage multinucleation.
 
Binding Assay Using Recombinant Fusion Proteins
 
Freshly isolated rat alveolar macrophages were plated at 5 
 
3 
 
10
 
6
 
 cells/ml
in triplicate wells using 96-well dishes (5 
 
3 
 
10
 
4
 
 cells/well). The cells were
cultured overnight in fusogenic milieu. At the indicated times, duplicate
sets of cells were supplemented with GSTÐCD44e, GSTÐCal, or GST at
the indicated concentrations. Binding proceeded overnight at 4
 
8
 
C. Media
was removed from one set of cells and replaced with fresh media lacking
recombinant protein to allow for dissociation. Dissociation proceeded for
3 h at 4
 
8
 
C. The media from all wells was then removed and the cells were
fixed for 30 min in 4% paraformaldehyde. Cells were rinsed three times
with PBS and blocked for 1 h in 5% milk/PBS. After three washes of 5
min in PBS, the cells were incubated with goat anti-GST for 30 min at
room temperature. After three washes of 5 min each in PBS, the cells
were incubated with rabbit antiÐgoat IgG-HRP for 30 min. After three fi-
nal washes of 5 min each in PBS, 100 
 
m
 
l of peroxidase substrate (Moss)
was added to each well and the optical density (OD) was read at 650 nm
using an ELISA plate reader. Specific binding was determined as the dif-
ference in average OD values between the two sets of cells.
 
Statistical Analysis
 
Data are expressed as mean 
 
6
 
 SD of mean. Comparative analyses of the
means were performed with appropriate controls using independent Stu-
dentÕs 
 
t
 
 test to determine the 99% confidence level (
 
P
 
 
 
, 
 
0.01).
 
Results
 
High Expression of CD44 by Fusing Macrophages
In Vivo and In Vitro
 
To investigate whether fusing macrophages expressed de-
tectable levels of CD44, rat osteoclast-like cells were in-
duced in vivo by implanting syngeneic bone particles intra-
muscularly as previously described (Vignery et al., 1989,
1990). Sections obtained from bone implants, as well as
from long bones, brain, liver, spleen, lymph nodes, kidney,
lung, skin, striated muscle, and pancreas were reacted with
mAb anti-CD44, anti-CD4, anti-MHCII, or IgG1, fol-
lowed by goat antiÐmouse IgG conjugated to Cy3. Al-
though each of these tissues hosts resident macrophages
and many of them contain cells such as lymphocytes and
epithelial cells known to express CD44, only osteoclast-
like cells from the bone implants exhibited a strong fluo-
rescent signal (Fig. 1 
 
A
 
) that was not detected in the pres-
ence of anti-CD4, anti-MHCII, or IgG1 (Fig. 1 
 
B
 
). The
signal was restricted to both mono- and multinucleated
cells that were closely apposed to the bone implants. In the
larger cells attached to the implants, the signal appeared
stronger distal to the bone, i.e., concentrated in the nonad-
herent domain of the plasma membrane. This is the do-
main that faces the incoming fusing macrophages. None of
the surrounding cells, such as muscle cells, fibroblasts, or
endothelial cells expressed a detectable level of fluores-
cence.
To investigate whether CD44 expression by macro-
phages was associated with cellÐcell interaction leading to
fusion, alveolar macrophages were isolated and cultured in
fusogenic conditions, i.e., plated at confluency, as previ-
ously described (Vignery et al., 1990). Macrophages cul-
tured in such conditions initiate fusion a few hours after
Figure 1. High expression of CD44 on fusing
macrophages in vivo (A) and in vitro (C and D).
Multinucleation was induced in vivo by implant-
ing rats intramuscularly with syngeneic bone par-
ticles that were recovered 10 d later and pro-
cessed for immunolocalization. Frozen sections
from bone implants were incubated with either
mAb anti-rat CD44 (A) or mouse IgG1 (B) fol-
lowed by goat antiÐmouse IgG F(ab9)2 frag-
ments conjugated to Cy3. Multinucleation was
induced in vitro by plating alveolar macrophages
on glass coverslips and culturing them under fu-
sogenic conditions for either 1 (C) or 3 d (D).
Cells were subjected to immunocytochemistry
using anti-rat CD44 followed by goat antiÐmouse
IgG F(ab9)2 fragments conjugated to Cy3. Note
the differences in fluorescence intensity between
fusing cells. Bars, 20 mm. 
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plating and reach 99% fusion within 3Ð4 d. Although both
resident and freshly plated alveolar macrophages failed to
express detectable level of CD44 expression by immuno-
cytochemistry (data not shown), their fusion was associ-
ated with a strong fluorescent signal that was detected as
soon as 24 h after plating (Fig. 1 
 
C
 
). By day three, the
plasma membrane of the unfused mononucleated mac-
rophages exhibited a strong signal whereas that of the
multinucleated ones had become lesser (Fig. 1 
 
D
 
). Neither
CD4 nor MHCII, which are both expressed by macro-
phages, were detectable by this technique suggesting that
their level of expression remained low, i.e., similar to that
of CD44 in nonfusing macrophages.
 
CD44 Expression Is Induced by Fusogenic Conditions
 
To investigate the kinetics of CD44 expression during in-
duction of fusion, rat alveolar macrophages were plated in
fusogenic conditions and CD44 expression was deter-
mined by ELISA as a function of time after plating. As
shown in Fig. 2 
 
A
 
, CD44 expression increased to reach a
peak at a time that varied between 24 and 48 h. CD44 de-
clined thereafter. In some experiments, a dramatic in-
crease was detected as early as 5Ð10 h after plating (data
not shown). This confirmed our morphological observa-
tion that CD44 expression was less abundant in multinu-
cleated than mononucleated fusing macrophages (Fig. 1
 
D
 
). In contrast to CD44, the expression of CD4 and
MHCII remained low, and was not altered by fusogenic
conditions in macrophages (Fig. 2 
 
A
 
). When subjected to
Northern blot analysis, CD44 transcripts were found to be
abundant in freshly isolated macrophages, and increased
by 36 and 13% in fusing alveolar and peritoneal cells, re-
spectively (Fig. 2 
 
B
 
). This suggested that the regulation of
CD44 mRNA expression in macrophages may be both
transcriptional and posttranscriptional.
 
CD44 Ligands Inhibit Macrophage Adhesion/Fusion
 
To analyze whether CD44 ligands, hyaluronic acid (HA),
chondroitin sulfate A (CSA) and osteopontin (OP), all of
which are extracellular matrix components, altered multi-
nucleation, alveolar macrophages were cultured in fuso-
genic conditions in the presence of increasing concentra-
tions of HA, CSA, or OP. Although alveolar macrophages
are all fused after 4 d of culture under fusogenic condi-
tions, the addition of HA, CSA, or OP prevented multinu-
cleation in a dose-dependent manner (Fig. 3 
 
A
 
). In the
presence of 1 mg/ml of HA, and to a lesser degree 1 mg/ml
CSA and 1 
 
m
 
M OP, macrophages failed to form giant cells.
To investigate whether CD44 played a role in macrophage
attachment to their substrate, cells were plated onto sur-
faces coated with PBS, HA, or CSA. Although neither
PBS nor CSA altered the adherence of macrophages, the
coating of the dish with HA strongly prevented macro-
phages from adhering (Fig. 3 
 
B
 
). Interestingly, this inhibi-
tion was reversed by the addition of 1 mg/ml of HA to the
culture medium, and to a lesser extent by the same con-
centration of CSA (Fig. 3 
 
B
 
, 
 
center panel
 
). This suggested
that the interaction of CD44 with HA was not required for
macrophage attachment to their substrate. Indeed, it sug-
gested that the possible clustering of CD44 receptors to
the adherent domain of macrophages driven by HA pre-
vented macrophage attachment. If so, soluble HA added
to the culture medium may have allowed for the redistri-
bution of CD44 to the nonadherent domain of the plasma
membrane and thereby secured the adherence of the mac-
rophages. This could even suggest that given the high ex-
pression level of CD44 molecules, their clustering to one
(adherent) domain of the plasma membrane prevented
(mechanistically) adhesion molecules (non-CD44) from
reaching and clustering there as well, thereby preventing
macrophage attachment. Altogether, our data suggested
Figure 2. Kinetics of CD44 expres-
sion in macrophages induced to
fuse in vitro (A). Rat alveolar
macrophages were isolated, plated
at 5 3 106 cells/ml in quadruplicate
wells, using 96-well dishes (5 3 104
cells/well), and cultured in fuso-
genic conditions for the indicated
times. CD44 expression on para-
formaldehyde fixed cells was deter-
mined by ELISA using mAb mouse
anti-rat CD44 followed by goat
antiÐmouse IgG-conjugated to
horseradish peroxidase (A and B).
Mouse mAbs anti-rat CD4 and
MHCII were used as controls.
Northern blot analysis of CD44 (B).
Each lane contained z8 mg of total
RNA from freshly isolated as well
as alveolar and peritoneal macro-
phages that had been cultured for
72 h under fusogenic conditions.
Hybridization was performed using
32P-labeled PCR generated CD44
and  b-actin probes.The Journal of Cell Biology, Volume 143, 1998 842
that macrophage attachment was not facilitated by HA-
CD44 interaction, and that indeed other adhesion mole-
cules might mediate their adhesion to a substrate.
HA Reduces CD44 Increased Expression by
Fusing Macrophages
To initiate studies on the mechanism by which HA, and to
a lesser extent CSA and OP inhibited macrophage multi-
nucleation, fusing alveolar macrophages were cultured in
the presence of CSA, HA, or OP, and CD44 expression
was determined by ELISA. As shown in Fig. 2, the cultur-
ing of macrophages in fusogenic conditions was associated
with a rapid and dramatic increase in CD44 expression.
Fig. 4 shows that HA appeared to significantly (Fig. 2 A)
and dose dependently (Fig. 2 B) prevent the increase in
CD44 expression that accompanies the onset of fusion.
This inhibition did not occur with either CSA or OP. BSA,
used as a negative control, also failed to alter the binding
of mAb anti-CD44 (Fig. 4 A). Because of the possibility
that mAb anti-CD44 binding was prevented by HA itself
which competed for the same site on CD44, fusing cells
were cultured in the absence or presence of HA, and fur-
ther treated or not with HA by adding HA to the mAb
anti-CD44 incubation buffer. Fig. 4 C shows that mAb anti-
CD44 binding was significantly reduced when mAb anti-
CD44 incubation buffer was supplemented with HA. This
suggested that HA and mAb anti-CD44 competed for the
same epitope on CD44. But mAb anti-CD44 binding was
further reduced when these cells were cultured in the pres-
ence of HA. This suggested that HA did reduce CD44 ex-
pression in fusing macrophages. Altogether, these data in-
dicated that the interaction of CD44 with its extracellular
ligands participated in the adhesion process leading to fu-
sion of macrophages.
The Extracellular Domain of CD44 Binds Fusing 
Macrophages and Prevents Multinucleation
Since the fusion of macrophages requires close mem-
braneÐmembrane attachment/adhesion, and since fusing
macrophages express high levels of CD44 on their surface,
we hypothesized that the extracellular domain of CD44 it-
self may bind a putative cell surface determinant on mac-
rophages and by so doing interfere with adhesion/fusion.
We therefore generated a recombinant soluble form of the
extracellular domain of CD44 attached to GST, hence a
GSTÐCD44e fusion protein. The addition of GSTÐCD44e
to fusing macrophages strongly and dose dependently pre-
vented multinucleation (Fig. 5 A). Neither GSTÐcalreticu-
lin (Fig. 5, GST-Cal) nor GST used as controls altered
multinucleation. Of interest, GSTÐCD44e and GSTÐCal
bound macrophages (Fig. 5 B). Although calreticulin is
known to bind many cell types in vitro, our data suggest
that CD44, and possibly its cell surface ligand, participates
in macrophageÐmacrophage interaction leading to fusion.Sterling et al. CD44 in MacrophageÐMacrophage Interaction 843
Figure 3. CD44 ligands in-
hibit macrophage adhesion/
fusion. (A) Rat alveolar mac-
rophages were isolated,
plated at 5 3 106 cells/ml in
quadruplicate wells, using 96-
well dishes (5 3 104 cells/
well), and cultured in fuso-
genic conditions for the indi-
cated times, in the absence or
presence of hyaluronic acid
(HA), chondroitin sulfate A
(CSA), or osteopontin (OP)
at the indicated concentra-
tions. (B) Alveolar macro-
phages were cultured as in A,
but in dishes coated with ei-
ther HA (1 mg/ml) or CSA
(1 mg/ml). Bars, 100 mm.The Journal of Cell Biology, Volume 143, 1998 844
Fusing Macrophages Express the Standard 
(Hematopoietic) Form of CD44
To identify the CD44 isoform expressed by fusing mac-
rophages, total RNA was isolated from fusing rat alveolar
macrophages was subjected to reverse transcription (RT)-
PCR. The use of primers located in the most 39 and 59 re-
gions of rat CD44 generated a PCR product of 1,138 bp
(data not shown). Using primers located at either end of
the extra- and intracellular domains generated PCR prod-
ucts of 827 and 218 bp, respectively. This suggested that
both the extra- and intracellular domains of CD44 from
fusing macrophages belonged to the standard form. To en-
sure that these PCR products encoded CD44, the full-
length RT-PCR 1,138 bp product was cloned into TA clon-
ing vector and subjected to DNA sequence analysis. DNA
sequencing confirmed that fusing rat alveolar macrophages
express the standard form of CD44 (data not shown).
Discussion
We have presented evidence that surface expression of
CD44 is highly and transiently induced by macrophages at
the onset of cellÐcell adhesion/fusion in vitro and in vivo.
We have also shown that CD44 ligands, HA, CSA, and
OP, and the recombinant extracellular domain of CD44 pre-
vent multinucleation. We therefore propose that CD44,
along with its putative cognate cell surface ligand, is possi-
bly a potential member of a protein machinery that partic-
ipates in macrophageÐmacrophage interaction leading to
fusion.
Although multinucleated osteoclasts and giant cells
have long been recognized, the mechanism by which their
mononucleated precursors adhere to and fuse with each
other remains unclear. Although a number of adhesion
molecules and regulatory proteins have been suggested to
participate in macrophage multinucleation, the nature of
the assays reported in the literature used to identify these
molecules did not allow one to investigate the direct role
of these molecules in cellÐcell adhesion and fusion. These
assays used bone marrow cells and monocytes; thus, cells
that are impure and have not yet acquired the status of the
macrophage. These cells require culturing time to further
differentiate and become fusion competent. In contrast,
we have used a highly pure and fast assay whereby cells
adhere to each other to initiate fusion within hours after
plating, and reach 99% multinucleation within 3Ð4 d. This
assay allows the investigation of molecules involved in
Figure 4. HA decreases CD44 surface expression. (A) Rat alveolar macrophages
were isolated, plated at 5 3 106 cells/ml in quadruplicate wells, using 96-well
dishes (5 3 104 cells/well), and cultured in fusogenic conditions for 2 d, in the ab-
sence or presence of 1 mg/ml BSA, chondroitin sulfate A (CSA) or B (CSB), hy-
aluronic acid (HA), or 1 mM osteopontin (OP). CD44 expression was determined
by ELISA using mAb mouse antiÐrat CD44 followed by goat antiÐmouse IgG-
conjugated to horseradish peroxidase. (B) Cells were cultured as in A in the ab-
sence or presence of decreasing concentrations of HA and CD44 expression was
determined by ELISA. (C) Cells were cultured as in A in the absence or presence
of either OP (1 mM) or HA (1 mg/ml) for 3 d. CD44 expression was determined
by ELISA in which mAb anti-CD44 incubation buffer was supplemented or not
with either OP (1 mM) or HA (1 mg/ml).Sterling et al. CD44 in MacrophageÐMacrophage Interaction 845
early cellÐcell interaction and possibly fusion (Vignery et al.,
1989). Indeed, using this assay, we reported earlier the pu-
rification of a protein the expression of which is induced
by fusogenic conditions in macrophages (Saginario et al.,
1995). The subsequent cloning of the cDNA coding for
that protein revealed that it belongs to the superfamily of
IgG (Saginario et al., 1998). The question as to whether
that protein associates with CD44 during cellÐcell interac-
tion remains open.
Although CD44 was long known to mediate cellÐcell in-
teraction/aggregation, its possible involvement in mac-
rophageÐmacrophage adhesion leading to fusion had not
yet been investigated. From our data, it appears that fu-
sion-competent macrophages express, in an inducible and
transient manner, a very high level of surface CD44. This
suggests that constitutive CD44 may secure the mononu-
cleated status of macrophages in tissues. It also suggests
that macrophage adhesion/fusion requires an overexpres-
Figure 5. Recombinant extracellular CD44 fusion protein (GST-
CD44e) inhibits macrophage fusion. (A) Rat alveolar macro-
phages were isolated, plated at 5 3 106 cells/ml in quadruplicate
wells, using 96-well dishes (5 3 104 cells/well), and cultured in fu-
sogenic conditions for 3 d, in the presence of increasing concen-
trations of GSTÐCD44e, GSTÐCal, and GST. (B) Cells were cul-
tured as in A for 17 h and then incubated for 3 h at 48C with
GSTÐCD44e. Binding was determined by ELISA using anti-
GST antibody coupled to horseradish peroxidase as described in
Materials and Methods. Specific binding was determined by sub-
tracting nonspecific binding from total binding for each concen-
tration of GSTÐCD44e. Bar, 100 mM. The Journal of Cell Biology, Volume 143, 1998 846
sion of CD44 in order to override extracellular ligands and
provide unoccupied CD44. This Òligand-freeÓ CD44 may
in turn participate in cellÐcell interaction by virtue of bind-
ing to a putative macrophage surface determinant. Al-
though the nature of that putative cell surface ligand for
CD44 has not been identified, it appears to bind the core
peptide of CD44. The engineering of myc-his-CD44e and
its expression by COS cells leads to the production of gly-
cosylated CD44 that failed to block fusion and bind mac-
rophages (data not shown). This might have been be due
to the glycosylation pattern imposed by COS cells on the
extracellular domain of CD44 that differed from that im-
posed by rat alveolar macrophages. It is possible that COS
cell sugar moieties added to CD44 hide its binding site and
prevent CD44 binding. It is also likely that COS cell-added
sugar moieties bind nonspecifically to other sites on mac-
rophages, thereby preventing CD44 from interacting with
its ligand. Indeed, we observed that partially deglycosy-
lated COS cell produced CD44e-recovered binding of mac-
rophages and prevented their multinucleation (data not
shown). This suggested that sugar moieties added to CD44
by cells other than alveolar macrophages may not be func-
tionally relevant. Macrophages appear to process CD44
posttranslationally in a tissue-specific manner (Camp et
al., 1991), and although circumstantial, alveolar macro-
phages do not fuse with peritoneal macrophages (our un-
published observation). The role of glycosylation of CD44
in macrophageÐmacrophage interaction remains an im-
portant subject to investigate.
It is interesting to note that the expression of macro-
phage surface molecules known to participate in cellÐcell
interaction such as CD4 and MHCII was not altered by fu-
sogenic conditions. Although their lack of induced expres-
sion does not exclude their participation in adhesion/fu-
sion, this could be further suggestive of a possible role for
CD44 in macrophageÐmacrophage interaction leading to
fusion.
The question as to how HA prevents macrophage multi-
nucleation is interesting. One possibility is that HA acti-
vates macrophages (Nobel et al., 1993) and we have previ-
ously reported that activation of macrophages prevents
fusion (Vignery et al., 1990). Another possibility is that
HA competes with the putative cell surface ligand for
CD44, thereby blocking CD44-ligand interaction and cellÐ
cell adhesion.
The fact that macrophages do not attach to HA-coated
surfaces suggests that CD44 may not be required for mac-
rophages to adhere onto a substrate. Indeed, it suggests
that the possible clustering of CD44 molecules to the ad-
herent domain of the plasma membrane of macrophages
may mechanistically prevent adhesion molecules from ac-
cessing that domain, thereby preventing macrophages
from adhering. This possibility is further suggested by the
fact that the addition of HA, and to a lesser extent CSA, to
the culture medium reverses this inhibitory effect of HA-
coated surfaces on macrophage attachment. Indeed, this
may be the case when macrophages adhere to, and fuse
onto bone that contains OP. There again, the presence of
HA and CSA in the extracellular microenvironment may
prevent the clustering of CD44 on the adherent domain of
the macrophages.
Although cellÐcell adhesion leading to fusion appears to
involve a complicated protein machinery, the present find-
ings open possibilities to investigate the role of CD44 and
its putative cell surface ligand in the interaction of not only
macrophages but also potentially those of sperm cells with
oocytes and myoblasts with myoblasts, the other develop-
mental cellÐcell adhesion/fusion events. Indeed, the mam-
malian oocyteÐcumulus complex contains an extracellular
matrix rich in HA (Cherr et al., 1990), and HA has been
suggested to interact with the sperm surface, at the time of
initiation of acrosome reaction (Vandevoort et al., 1997).
Our observation that CD44 is highly expressed by fusing
macrophages and that both CD44 ligands and soluble
CD44 prevent multinucleation, opens avenues to study the
role of CD44 in osteoclast and giant cell differentiation.
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